Sanofi Pasteur and GSK Begin to Ship Flu Vaccine for 2017/18 Season
Published on
July 17, 2017 at 10:34:00 AM PDT July 17, 2017 at 10:34:00 AM PDTth, July 17, 2017 at 10:34:00 AM PDT
The U.S. Food and Drug Administration (FDA) has released the first doses of influenza vaccine manufactured by Sanofi Pasteur and GSK. Sanofi is projected to manufacture 70 million doses for this year's flu season. GSK expects to supply up to 40 million doses.
Beginning in August, NMS anticipates delivering a wide range of Fluzone products including High-Dose, Quadrivalent vials and Quadrivalent syringes.